![]() |
|
|
Vol. 296, Issue 3, 996-1005, March 2001
Oxygen Signaling Group, Center for Research into Human Development,
Tayside Institute of Child Health, Faculty of Medicine, Ninewells
Hospital and Medical School, University of Dundee, Dundee, Scotland,
United Kingdom (J.J.H., S.C.L.); and the Departments of Biology
(B.S.-G.), Faculty of Arts and Sciences, Human Morphology and
Physiology (N.E.S.), Faculty of Medicine, American University of
Beirut, Beirut, Lebanon
The therapeutic immunopharmacological potential of glutathione in the
alveolar epithelium is not well characterized. We developed an in vitro
model of fetal alveolar type II epithelial cells to investigate the
effect of redox disequilibrium on chemioxyexcitation (
pO2/ROS) induced up-regulation of
pro-inflammatory cytokines. Buthionine sulfoximine, an irreversible
inhibitor of
-glutamylcysteine synthetase, the rate-limiting enzyme
in glutathione (GSH) biosynthesis, induced intracellular reactive
oxygen species (ROS) and the release of interleukin-1
(IL-1
),
IL-6, and tumor necrosis factor-
. Chloroethyl nitrosourea, which
blocks the NADPH-dependent recycling of oxidized glutathione (GSSG),
reduced ROS-induced cytokine production, similar to pyrrolidine
dithiocarbamate, an antioxidant/pro-oxidant thiuram, which elevates
GSSG. The antioxidant and GSH precursor, acetylcysteine, abrogated
cytokine release concomitant with suppression of ROS, an effect
mimicked by
-glutamylcysteinyl-ethyl ester, a cell permeant GSH.
Cysteine, the rate-limiting amino acid in the de novo synthesis of GSH,
administered as oxothiazolidine carboxylate and adenosylmethionine,
mitigated the chemioxyexcitation-dependent cytokine release. Ebselen,
an anti-inflammatory antioxidant, which mimics the effect of
glutathione peroxidase, neutralized ROS by the GSH-peroxidase-coupled
reaction, thereby blocking the pathway to cytokine enhancement. Our
results indicate that modulating redox equilibrium by pharmacological
thiols exhibits differential regulation on pro-inflammatory cytokines,
thus bearing clinical consequences for the therapeutic treatment of
pediatric distresses in pathophysiology.
This article has been cited by other articles:
![]() |
M. Griese, J. Ramakers, A. Krasselt, V. Starosta, S. van Koningsbruggen, R. Fischer, F. Ratjen, B. Mullinger, R. M. Huber, K. Maier, et al. Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 822 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Powell, K. A. Strauss, C. Wiley, M. Zhan, and J. G. Morris Jr. Inflammatory Cytokine Response to Vibrio vulnificus Elicited by Peripheral Blood Mononuclear Cells from Chronic Alcohol Users Is Associated with Biomarkers of Cellular Oxidative Stress Infect. Immun., July 1, 2003; 71(7): 4212 - 4216. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vassilakopoulos, M.-H. Karatza, P. Katsaounou, A. Kollintza, S. Zakynthinos, and C. Roussos Antioxidants attenuate the plasma cytokine response to exercise in humans J Appl Physiol, March 1, 2003; 94(3): 1025 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vassilakopoulos, P. Katsaounou, M.-H. Karatza, A. Kollintza, S. Zakynthinos, and C. Roussos Strenuous Resistive Breathing Induces Plasma Cytokines: Role of Antioxidants and Monocytes Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1572 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Haddad, S. C. Land, W. O. Tarnow-Mordi, M. Zembala, D. Kowalczyk, and R. Lauterbach Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. I. Differential Regulation of Lipopolysaccharide-Mediated Proinflammatory Cytokine (Interleukin-6 and Tumor Necrosis Factor-alpha ) Biosynthesis in Alveolar Epithelial Cells J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 559 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Haddad, S. C. Land, W. O. Tarnow-Mordi, M. Zembala, D. Kowalczyk, and R. Lauterbach Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. II. Evidence for the Involvement of an Inhibitory-kappa B/Nuclear Factor-kappa B-Sensitive Pathway in Alveolar Epithelial Cells J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 567 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Haddad and S. C. Land Amiloride Blockades Lipopolysaccharide-Induced Proinflammatory Cytokine Biosynthesis in an Ikappa B-alpha /NF-kappa B-Dependent Mechanism . Evidence for the Amplification of an Antiinflammatory Pathway in the Alveolar Epithelium Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 114 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Porro, J.-H. Lee, J. de Azavedo, I. Crandall, T. Whitehead, E. Tullis, T. Ganz, M. Liu, A. S. Slutsky, and H. Zhang Direct and indirect bacterial killing functions of neutrophil defensins in lung explants Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1240 - L1247. [Abstract] [Full Text] [PDF] |
||||